Web Analytics

3 Latest Announced Rounds

  • $500,000,000
    Unknown

    1 Investors

    Investment Management
    Apr 22nd, 2025
  • $8,021,670
    Series A

    2 Investors

    Wireless Services
    Apr 22nd, 2025
  • $7,500,000
    Seed

    2 Investors

    Computer & Network Security
    Apr 22nd, 2025
$2,212.64M Raised in 66 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Mable | Neurolytic Healthcare

start up
United States - San Francisco, California
  • 27/07/2022
  • Seed
  • $3,200,000

Migraines are heritable. Uncover the link between your genetics and migraines to help prevent your migraine in advance and get medication delivered directly to your door.


Related People

Roman RothaermelCo Founder

Roman Rothaermel United Kingdom - London, England

Before founding Mable, I was a researcher at the University of Oxford working at the intersection between neuroscience, data science and pharmacology. Today at Mable, we're using data-driven approaches to fight neurological conditions starting with migraines - a problem that affects 12% of the population and is in urgent need of innovation in care quality and delivery mechanisms.